Rating date
Jul 20, 2026
21 days ago
Pfizer (PFE) Stock Analysis
BUYPFE Equity Research — BUY — July 2026
Desk view
BUY
5D move
—
Awaiting market data
Peer rank
69p
Research history
2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 moreInvestment card · PFE
Here is the analysis for PFE (Pfizer Inc.).
Desk rating
BUY
Tactical BUY · 12M BUY
Horizon
Short to medium term
Confidence
High
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Bias
BUY
Catalysts
- Death cross is in effect — the 50-day SMA ($25.23) is now below the 200-day SMA ($25.35), a bearish medium-term signal. Price trading below both averages reinforces this.
- Near-term momentum is improving — RSI has rebounded from oversold to neutral (49.75), and MACD is narrowing toward zero. This suggests the selling climax may be behind the stock.
- Recovery off lows is intact but untested — from the $23.67 trough, PFE has rallied ~5.8% to $25.05. The next resistance zone is the 50-day SMA (~$25.23) and the 200-day SMA (~$25.35).
Risks
- Event-driven repricing risk if expectations diverge from incoming evidence.
Market chart
Price context alongside the research narrative.
PFE Research Note
Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.
WebserviceX · Agentic Research Desk
PFE Equity Research Note
PFE Stock Rating Summary
PFE bias
BUY
Horizon
Short to medium term
PFE key risk
Event-driven repricing risk if expectations diverge from incoming evidence.
PFE catalyst watch
Death cross is in effect — the 50-day SMA ($25.23) is now below the 200-day SMA ($25.35), a bearish medium-term signal. Price trading below both averages reinforces this.
Invalidation
Thesis weakens if catalysts slip or risk markers breach stated levels.
Confidence
High
How the call aged · 5D
—Awaiting market dataPeer 69pExpandCollapse
How the call aged · 5D
—Awaiting market dataPeer 69p
Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:33.874144+00:00.
5D move
—
2026-07-20 → awaiting
Outcome
Awaiting market data
5D trend
+1.10%
Vol (20D ann.)
+23.80%
vs SPY: +2.05%
Close 24.75 → — (USD, vendor closes)
Publish QC
passedExpandCollapse
Publish QC
passed
Pipeline fingerprint 2f45a102687f75c0
Trace 90a74da0…
No QC issues recorded.